TY - JOUR
T1 - Temple monkeys and health implications of commensalism, Kathmandu, Nepal
AU - Jones-Engel, Lisa
AU - Engel, Gregory A.
AU - Heidrich, John
AU - Chalise, Mukesh
AU - Poudel, Narayan
AU - Viscidi, Raphael
AU - Barry, Peter A.
AU - Allan, Jonathan S.
AU - Grant, Richard
AU - Kyes, Randy
PY - 2006
Y1 - 2006
N2 - The threat of zoonotic transmission of infectious agents at monkey temples highlights the necessity of investigating the prevalence of enzootic infectious agents in these primate populations. Biological samples were collected from 39 rhesus macaques at the Swoyambhu Temple and tested by enzyme-linked immunosorbent assay, Western blot, polymerase chain reaction, or combination of these tests for evidence of infection with rhesus cytomegalovirus (RhCMV), Cercopithecine herpesvirus 1 (CHV-1), simian virus 40 (SV40), simian retrovirus (SRV), simian T-cell lymphotropic virus (STLV), simian immunodeficiency virus (SIV), and simian foamy virus (SFV). Antibody seroprevalence was 94.9% to RhCMV (37/39), 89.7% to SV40 (35/39), 64.1% to CHV-1 (25/39), and 97.4% to SFV (38/39). Humans who come into contact with macaques at Swoyambhu risk exposure to enzootic primateborne viruses. We discuss implications for public health and primate management strategies that would reduce contact between humans and primates.
AB - The threat of zoonotic transmission of infectious agents at monkey temples highlights the necessity of investigating the prevalence of enzootic infectious agents in these primate populations. Biological samples were collected from 39 rhesus macaques at the Swoyambhu Temple and tested by enzyme-linked immunosorbent assay, Western blot, polymerase chain reaction, or combination of these tests for evidence of infection with rhesus cytomegalovirus (RhCMV), Cercopithecine herpesvirus 1 (CHV-1), simian virus 40 (SV40), simian retrovirus (SRV), simian T-cell lymphotropic virus (STLV), simian immunodeficiency virus (SIV), and simian foamy virus (SFV). Antibody seroprevalence was 94.9% to RhCMV (37/39), 89.7% to SV40 (35/39), 64.1% to CHV-1 (25/39), and 97.4% to SFV (38/39). Humans who come into contact with macaques at Swoyambhu risk exposure to enzootic primateborne viruses. We discuss implications for public health and primate management strategies that would reduce contact between humans and primates.
UR - http://www.scopus.com/inward/record.url?scp=33744914090&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33744914090&partnerID=8YFLogxK
U2 - 10.3201/eid1206.060030
DO - 10.3201/eid1206.060030
M3 - Article
C2 - 16707044
AN - SCOPUS:33744914090
SN - 1080-6040
VL - 12
SP - 900
EP - 906
JO - Emerging infectious diseases
JF - Emerging infectious diseases
IS - 6
ER -